Novomedicon ApS: Financial statements 2023
CVR: 38818791
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Novomedicon ApS (CVR 38818791) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -7,258 and a net result of DKK -7,262 compared with DKK -7,312 the year before. Equity in the 2023 report amounted to DKK 20,261. The solvency ratio was 2.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -7,258
- Profit/Loss
- DKK -7,262
- Equity
- DKK 20,261
- Total Assets
- DKK 742,814
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -7K | -7K | 20K | 1 |
| 2022 | - | -7K | -7K | 28K | - |
| 2021 | - | - | -522 | 35K | - |
| 2020 | - | 0 | -5K | -5K | 1 |
| 2019 | - | 0 | 0 | 100 | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Novomedicon ApS has published its annual report for 2022. Gross profit came to DKK -6,982, and the net result was DKK -7,312.
About Novomedicon ApS
Novomedicon ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2017. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named Novomedicon IVS. The management consists of Jens Dahlgaard Hove. The company is owned by Jens Dahlgaard Hove. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -7,598 and a net result of DKK -7,598 compared with DKK -7,538 the year before. Equity in the 2025 report amounted to DKK 5,125.
